New Results

A discrete event simulation to evaluate the cost effectiveness of germline BRCA1 and BRCA2 testing in UK women with ovarian cancer

Anthony Eccleston, Anthony Bentley, Matthew Dyer, Ann Strydom, Wim Vereecken, Angela George, Nazneen Rahman
doi: https://doi.org/10.1101/060418

Article usage

Article usage: June 2016 to March 2021

AbstractFullPdf
Jun 2016312024
Jul 2016299078
Aug 2016143055
Sep 201667038
Oct 201659035
Nov 201642042
Dec 201635031
Jan 201755040
Feb 201748022
Mar 201746018
Apr 201727016
May 201754023
Jun 201737020
Jul 201737022
Aug 201748021
Sep 201745030
Oct 201733023
Nov 201739016
Dec 201736013
Jan 20182309
Feb 201831013
Mar 201846020
Apr 201832020
May 201847020
Jun 201830017
Jul 201851014
Aug 201869017
Sep 201854018
Oct 201834020
Nov 201834016
Dec 201833021
Jan 201933020
Feb 201939013
Mar 201956419
Apr 201919421
May 201914420
Jun 201926216
Jul 201923818
Aug 201935513
Sep 201950816
Oct 2019431625
Nov 2019231114
Dec 201932713
Jan 202024916
Feb 2020672716
Mar 2020301619
Apr 202014212
May 202027814
Jun 202018514
Jul 202011313
Aug 202011410
Sep 20203833
Oct 20202099
Nov 202027156
Dec 202021913
Jan 20211327
Feb 202110208
Mar 2021221
Back to top
Posted June 23, 2016.
Download PDF
Email
A discrete event simulation to evaluate the cost effectiveness of germline BRCA1 and BRCA2 testing in UK women with ovarian cancer
Anthony Eccleston, Anthony Bentley, Matthew Dyer, Ann Strydom, Wim Vereecken, Angela George, Nazneen Rahman
bioRxiv 060418; doi: https://doi.org/10.1101/060418
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools

Subject Area